Medical Computational Research Environment (MediCoRE)

As part of MediCoRE (Medical Computational Research Environment), a national high-performance computing platform for health data is being developed.

This platform is designed at its core as a secure processing environment (SPE). In addition, a patient portal, archiving solutions and accompanying scientific, technical, and innovation-promoting services provided by core units are planned. Key features of MediCoRE are: secure and GDPR-compliant data processing, cross-location access at national level, integration of a wide range of data types and data sets from a variety of healthcare and research sources, AI-optimized and EHDS-ready.

MediCoRE aims to contribute to addressing the challenges of data use and the development of data-based solutions and AI models in health research, to identifying risk factors and the prerequisites for individualized risk prediction, and to developing innovative diagnostic and therapeutic solutions.

The project was initiated in Q3/2024 by a consortium consisting of BIH and four Helmholtz institutions (Helmholtz München, CISPA, DKFZ, and MDC Berlin) with an application under the acronym SuperCoHD in the BMFTR prioritization process for large national research infrastructures (FIS).

Based on feedback from this process, BIH is currently conducting a pilot phase with the gradual development of a minimum viable product by Q3/2027. The goal is to demonstrate the feasibility and added value of such a platform and to prepare for further calls for proposals to strengthen research infrastructures and platforms. The pilot phase includes collecting and differentiating use cases along which MediCoRE can be developed, setting up an initial infrastructure based on local preliminary stages to implement these use cases and demonstrate the functionality of MediCoRE, and realizing a platform that includes core units beyond the infrastructure. The aim is to establish a one-stop shop for health data research designed for different user groups.

The pilot phase will also include a value creation analysis and regulatory assessments as a basis for use, as well as sustainable financial planning and risk analysis.